Display options
Share it on

J Dev Phys Disabil. 2016;28:101-112. doi: 10.1007/s10882-015-9455-z. Epub 2015 Oct 19.

Eye Gaze Technology as a Form of Augmentative and Alternative Communication for Individuals with Rett Syndrome: Experiences of Families in The Netherlands.

Journal of developmental and physical disabilities

Gillian S Townend, Peter B Marschik, Eric Smeets, Raymond van de Berg, Mariёlle van den Berg, Leopold M G Curfs

Affiliations

  1. Rett Expertise Centre - Governor Kremers Centre, Maastricht University Medical Centre, PO Box 616, 6200 MD Maastricht, The Netherlands.
  2. Institute of Physiology, Research Unit iDN - Interdisciplinary Developmental Neuroscience, Medical University of Graz, Graz, Austria ; Center of Neurodevelopmental Disorders (KIND), Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  3. Rett Expertise Centre - Governor Kremers Centre, Maastricht University Medical Centre, PO Box 616, 6200 MD Maastricht, The Netherlands ; Division of Balance Disorders, Department of Otorhinolaryngology and Head and Neck Surgery, Faculty of Health Medicine and Life Sciences, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands ; Faculty of Physics, Tomsk State University, Tomsk, Russian Federation.
  4. Nederlandse Rett Syndroom Vereniging, Dutch Rett Syndrome Parent Association, Utrecht, The Netherlands.

PMID: 27069348 PMCID: PMC4785214 DOI: 10.1007/s10882-015-9455-z

Abstract

This paper provides a brief report on families' experiences of eye gaze technology as one form of augmentative and alternative communication (AAC) for individuals with Rett syndrome (RTT), and the advice, training and support they receive in relation to this. An online survey exploring communication and AAC was circulated to 190 Dutch families; of the 67 questionnaires that were returned, 63 had answered questions relating to eye gaze technology. These 63 were analysed according to parameters including: experiences during trial periods and longer-term use; expert knowledge, advice and support; funding; communicative progress; and family satisfaction. 20 respondents were using or had previous experience of using an eye gaze system at the time of the survey, 28 of those with no prior experience wanted to try a system in the future. Following a trial period, 11 systems had been funded through health insurance for long-term use and two families had decided a system was not appropriate for them. Levels of support during trials and following long-term provision varied. Despite frustrations with the technology, satisfaction with the systems was higher than satisfaction with the support. The majority of families reported progress in their child's skills with longer term use. These findings suggest that although eye gaze technologies offer potential to individuals with RTT and their families, greater input from suppliers and knowledgeable AAC professionals is essential for individuals and families to benefit maximally. Higher levels of training and support should be part of the 'package' when an eye gaze system is provided.

Keywords: Augmentative and alternative communication (AAC); Communication; Eye gaze technology; Eye tracking; Rett syndrome; Support and training

References

  1. J Dev Phys Disabil. 2010 Apr;22(2):105-118 - PubMed
  2. Int J Lang Commun Disord. 2012 Mar-Apr;47(2):115-29 - PubMed
  3. Pediatr Neurol. 2012 Jul;47(1):25-9 - PubMed
  4. Ment Retard Dev Disabil Res Rev. 2002;8(2):61-5 - PubMed
  5. Brain Dev. 2002 Aug;24(5):281-3 - PubMed
  6. Mol Syndromol. 2012 Apr;2(3-5):113-127 - PubMed
  7. Eur Child Adolesc Psychiatry. 2000 Sep;9(3):227-33 - PubMed
  8. Dev Med Child Neurol. 2003 May;45(5):325-37 - PubMed
  9. Neurobiol Learn Mem. 2011 Nov;96(4):637-46 - PubMed
  10. Res Dev Disabil. 2012 Nov-Dec;33(6):1749-56 - PubMed
  11. Nat Genet. 1999 Oct;23(2):185-8 - PubMed
  12. Disabil Rehabil. 2015;37(15):1324-33 - PubMed
  13. Ann Neurol. 2010 Dec;68(6):944-50 - PubMed
  14. Pediatr Neurol. 2012 Apr;46(4):240-2 - PubMed
  15. Dev Neurorehabil. 2016;19(1):17-25 - PubMed
  16. Pediatr Neurol. 2014 Nov;51(5):650-6 - PubMed
  17. Clin Genet. 2013 Dec;84(6):572-6 - PubMed
  18. Dev Med Child Neurol. 2013 Apr;55(4):364-71 - PubMed
  19. Arq Neuropsiquiatr. 2009 Mar;67(1):50-4 - PubMed
  20. Public Health Genomics. 2015;18(4):233-6 - PubMed
  21. Dev Med Child Neurol. 2013 Apr;55(4):301-2 - PubMed
  22. Augment Altern Commun. 2006 Mar;22(1):48-61 - PubMed
  23. J Intellect Disabil Res. 2006 Sep;50(Pt 9):662-6 - PubMed
  24. Res Dev Disabil. 2013 Oct;34(10):3133-8 - PubMed
  25. Int J Lang Commun Disord. 2013 Jul-Aug;48(4):366-81 - PubMed
  26. Augment Altern Commun. 2006 Jun;22(2):85-99 - PubMed

Publication Types